Fecal microbiota transplantation for treating axial spondyloarthritis
Official title: Donor Versus Autologous Fecal Microbiota Transplantation for Axial Spondyloarthritis: a Double Blind, Placebo-Controlled, Randomized Trial
Run by University Hospital of North Norway · NCT06451588 · Data updated 2026-11-12
This study is testing if a treatment using gut bacteria from healthy donors can help people with axial spondyloarthritis who aren't feeling better with their current medications.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 99 (estimated) |
| Sponsor | University Hospital of North Norway Academic / other |
| Locations | 1 site (Tromsø) |
| Status | Recruiting |
| Started | June 1, 2024 |
| Main results expected | May 2027 |
| Study ends | November 2027 |
| Registry record updated | August 14, 2026 |
| Trial ID | NCT06451588 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals diagnosed with axial spondyloarthritis who have active disease and have not found relief from NSAIDs or biologic treatments.
✕Probably not a fit
Patients with severe immune deficiencies, active inflammatory bowel disease, or those who have previously undergone FMT may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of fecal microbiota transplantation (FMT) in patients with axial spondyloarthritis who have not achieved satisfactory relief from biologic therapies. The study is randomized and double-blind, meaning neither the participants nor the researchers know who receives the FMT or a placebo. Participants will receive a single enema treatment and will be monitored for changes in disease activity, pain, and fatigue over a 90-day period. The trial aims to determine if FMT can restore gut microbiota composition and improve symptoms in these patients.
Why it matters
Potential benefit: If successful, this treatment could provide significant relief from symptoms for patients with axial spondyloarthritis who do not respond well to current therapies.
How similar studies have gone: While the use of fecal microbiota transplantation is a novel approach in this context, similar studies in other conditions have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Axial Spondyloarthritis according to the ASAS classification criteria * Active disease defined as ASDAS ≥2.1 with elevated CRP ≥3 OR active inflammation on MRI within the last 3 months * Onset of axial SpA within last 10 years * Unsatisfactory relief of NSAIDs * On stable immunomodulatory treatment (TNFi, IL17i or JAKi) the last 3 months OR without immunomodulatory treatment last 3 months Exclusion Criteria: * Planned dose adjustment or change in immunomodulatory treatment the next 90 days * Disease or disorder with life expectancy of ≤5 years * Severe immune deficiency (acquired, congenital og du to medication) * Previous treatment with FMT * Regular use of opioids with the exception of codeine and tramadol * Any specific diagnosis that could explain or contribute to the patients back pain (e.g. tumor, fracture, infection or degenerative disease) * Inflammatory spinal disease other than axSpA * Severe psychiatric disorder, alcohol- or drug abuse * Active inflammatory bowel disease * Microscopic colitis, diverticulitis or ileus * Active psoriasis * Fibromyalgia * Abdominal surgery excluding appendectomy, cholecystectomy, hysterectomy, caesarian section, sapling-ooforectomy and hernia surgery * Malignant disease excluding basalioma and melanoma stage 1 * Conditions with expected necessary treatment with antibiotics during the study period, e.g. periodontitis end ischemic digital ulcers * Treatment with antibiotics 12 weeks prior to study entry * Pregnancy, lactation or planned pregnancy within the next 3 months * Contraindications for rectal catheter insertion * Planned rehabilitation program the next 90 days * Limited ability to comply with protocol requirements, including biobank participation
Where it's running
-
University Hospital North Norway
Tromsø, Norway Recruiting
Study contacts
- Study coordinator: Gunnstein Bakland, MD PhD
- Email: gunnstein.bakland@unn.no
- Phone: +4795860791
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gene expression profiles in spinal tuberculosis
This study is trying to see if different gene patterns in spinal tuberculosis can help doctors better understand and treat the disease, especially in people with HIV.
-
Comparing two techniques for wrist fusion in patients with post-traumatic arthritis
This study is testing two different surgery techniques for wrist fusion to see which one helps adults with post-traumatic arthritis feel better and regain more movement in their wrists.
-
Surface topography and spine damage in radiographic axial spondyloarthritis
This study tests whether a radiation-free 3D surface topography method can reflect spine damage and sagittal balance in adults with radiographic axial spondyloarthritis.
-
Treatment options for Dupuytren's contracture
This study is testing whether adding a corticosteroid injection to a needle treatment helps people with Dupuytren's contracture move their fingers better.
-
Accelerated MRI techniques for assessing cartilage health
This study is testing new, faster MRI methods to see if they can help people at risk for osteoarthritis by checking the health of their cartilage more accurately.
-
HB0017 Injection safety and PK in low-weight adults at different injection sites
This early-phase study tests a single subcutaneous HB0017 injection in healthy, low-weight adults and compares how the body processes the drug when injected at different sites.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.